Baird analyst Andrew Wittmann raised the firm’s price target on Healthcare Services (HCSG) to $13 from $12 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results and said things are heading in the right direction.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
- Healthcare Services Group: Strong Performance and Promising Outlook with Buy Rating
- Healthcare Services upgraded to Buy from Neutral at UBS
- Healthcare Services Group Reports Strong Q1 2025 Results
- Healthcare Services Group Reports Record Revenue and Optimistic Outlook
- Healthcare Services reports Q1 EPS 23c, consensus 19c